Baveno VI criteria as a prognostic factor for clinical complications in patients with compensated cirrhosis.
BACKGROUND
Combination of liver stiffness measurement and platelets count is a tool to safely rule out varices needing treatment (VNT) in patients with compensated advanced chronic liver disease (cACLD).


AIMS
to evaluate 4-year liver-related complications and survival in low-risk patients according to Baveno VI criteria.


METHODS
we conducted a monocentric retrospective analysis of prospectively collected data of all consecutive patients, with cirrhosis (LSM≥12.5 kPa) and without previous complication, evaluated between 2012 and 2015. Liver-related complications and survival were compared between 2 groups of patients: favourable (LSM< 20 kPa and platelet count>150.000/mm3) and unfavourable Baveno VI status patients (LSM ≥ 20 kPa or platelet count ≤150.000/mm3).


RESULTS
455 patients with cACLD were analysed. Two hundred patients had favourable Baveno VI criteria, 3.6% with VNT. The 4-year probability of being free of acute decompensation was higher in low-risk patients (94.4 ± 1.8% vs. 85.7%±2.6%, p = 0.018). Unfavourable Baveno status was independently associated with acute decompensation. The probability of being free of HCC was significantly higher in low-risk patients (94.2 ± 1.8% vs. 87.6 ± 2.4%, p = 0.048). Liver-related mortality was not different between the 2 groups (p = 0.56).


CONCLUSION
The Baveno VI criteria could predict clinical outcome in cACLD.
['Asesio|Nicolas|N|', 'Pollo-Flores|Priscila|P|', 'Caliez|Olivier|O|', 'Munteanu|Mona|M|', 'Ngo|An|A|', 'Ngo|Yen|Y|', 'Poynard|Thierry|T|', 'Thabut|Dominique|D|', 'Rudler|Marika|M|']
Compensated advanced chronic liver disease Hepatocellular carcinoma Portal hypertension